WELL AND BEYOND LTD

Executive Summary

Well and Beyond Ltd is a nascent private specialist medical practice with early-stage financials reflecting startup challenges typical in the sector. Positioned in a competitive and highly regulated market, its clinical leadership is a key asset, but it must carefully manage cash flow and scale operations to capitalize on growing demand for private specialist healthcare services in the UK.

WELL AND BEYOND LTD - Analysis Report

Company Number: 14761591

Analysis Date: 2025-07-20 16:37 UTC

1. Industry Classification
   Well and Beyond Ltd operates under SIC code 86220, classifying it within the "Specialists medical practice activities" sector. This sector typically includes private medical practitioners and specialist healthcare services outside the NHS framework. Characteristics of this sector include reliance on skilled professionals (often medically qualified), high regulatory oversight, and a market driven by patient demand for specialized healthcare services. Companies in this field are usually small to medium-sized, with a focus on quality of care, patient confidentiality, and often niche or personalized treatment offerings.

2. Relative Performance
   As a newly incorporated private limited company (established March 2023), Well and Beyond Ltd has filed its first accounts ending March 2024. The financials reveal a net current liability position of £2,035 and net assets at the same negative figure, indicating an initial operating loss or startup investment phase. With only £354 in cash and £4,425 in inventories, the working capital is negative, which is not uncommon in the early stage of specialist medical practices due to upfront costs such as equipment, premises, and regulatory compliance. The company has no employees on record and minimal share capital (£2), which contrasts with typical established specialist practices that usually have multiple practitioners and staff.

Compared to industry benchmarks, specialist medical practices generally show positive net assets and working capital once operational, reflecting stable cash flows from patient services and insurance reimbursements. The negative equity here signals the company is in an embryonic stage and has yet to scale operations or generate sustainable revenue.

3. Sector Trends Impact
   The UK specialist medical practice sector has been subject to several trends affecting new entrants like Well and Beyond Ltd:

• Increasing patient preference for private healthcare alternatives due to NHS waiting times, which creates growth opportunities.
• Rising regulatory and compliance costs, including data protection and clinical governance, increasing operational overhead.
• Technological adoption such as telemedicine is reshaping service delivery but requires upfront investment.
• Competition from larger multi-disciplinary clinics and hospital groups, which benefit from economies of scale.
• Post-pandemic demand fluctuations, with some specialties seeing rebound in elective procedures, while others face uncertainty.

For a nascent company, these dynamics present both a challenge—due to capital and operational demands—and an opportunity if it can carve out a niche or offer differentiated specialist services.

4. Competitive Positioning
   Well and Beyond Ltd currently appears as a niche newcomer in the specialist medical practice market. Its strengths include leadership by medically qualified directors (Dr Ella Shalit and formerly Dr Elizabeth Torosyan), which supports clinical credibility. However, the absence of employees and negative net assets suggest limited operational capacity and financial resilience compared to established competitors.

Typical competitors in this sector often have broader patient bases, established referral networks, and better working capital positions to support marketing, staff, and technology investments. Well and Beyond Ltd's early-stage financials indicate it is in the setup or pre-revenue phase, which is normal but underlines the need for careful cash flow management and strategic growth planning.

Summary: Well and Beyond Ltd is a very early-stage private specialist medical practice facing typical startup challenges such as negative working capital and limited operational scale. Positioned in a regulated and competitive sector with strong demand drivers, its future success will depend on building patient volumes, managing costs, and differentiating from larger entities while navigating sector trends like increasing regulation and digital transformation.